Entecavir or tenofovir monotherapy prevents HBV recurrence in liver transplant recipients: A 5-year follow-up study after hepatitis B immunoglobulin withdrawal-Reference-Cited by-同舟云学术

Entecavir or tenofovir monotherapy prevents HBV recurrence in liver transplant recipients: A 5-year follow-up study after hepatitis B immunoglobulin withdrawal

Published:2018-09 Issue:9 Volume:50 Page:944-953
ISSN:1590-8658
Container-title:Digestive and Liver Disease
language:en
Short-container-title:Digestive and Liver Disease

Author:

Manini Matteo A.^ORCID,Whitehouse Gavin,Bruce Matthew,Passerini Matteo,Lim Tiong Y.,Carey Ivana,Considine Aisling,Lampertico Pietro,Suddle Abid,Heaton Nigel,Heneghan Michael,Agarwal Kosh

Publisher

Elsevier BV

Subject

Gastroenterology,Hepatology

Reference35 articles.

1. http://www.who.int/mediacentre/factsheets/fs204/en/. Updated July 2016.

2. Trends in waiting list registration for liver transplantation for viral hepatitis in the United States;Kim;Gastroenterology,2009

3. Prevention of hepatitis B virus recurrence after liver transplantation in cirrhotic patients treated with lamivudine and passive immunoprophylaxis;Marzano;J Hepatol,2001

4. Lamivudine plus low-dose hepatitis b immunoglobulin to prevent recurrent hepatitis B following liver transplantation;Gane;Gastroenterology,2007

5. Prevention of recurrent hepatitis B virus infection after liver transplantation: hepatitis B immunoglobulin, antiviral drugs, or both? Systematic review and meta-analysis;Katz;Transpl Infect Dis,2010

Cited by 35 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Efficacy of Newer Nucleos(t)ide Analogs After Hepatitis B Immunoglobulin Discontinuation Against Hepatitis B and D Recurrence in Liver Transplant Recipients;Transplantation;2024-04-01

2. Asian Pacific Association for the Study of the Liver clinical practice guidelines on liver transplantation;Hepatology International;2024-02-28

3. Advances and Challenges in Managing Hepatitis D Virus: Evolving Strategies;Current Hepatology Reports;2024-02-01

4. The BIG question: Can we stop the use of HBIG?;Liver Transplantation;2024-01-31

5. Enhanced prognosis of HCC patients undergoing radical treatments with tenofovir versus entecavir: A meta-analysis based on propensity score matching studies;Asian Journal of Surgery;2024-01